Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Clinical trial NCT05163834 · COMPLETED

Trial details

NCT number: NCT05163834
Sponsor: argenx
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-11-17
Primary completion: 2022-03-08
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.